Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions-Reference-Cited by-同舟云学术

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

Published:2008-06-11 Issue:10 Volume:18 Page:2164-2173
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Sieber Martin A.,Lengsfeld Philipp,Frenzel Thomas,Golfier Sven,Schmitt-Willich Heribert,Siegmund Fred,Walter Jakob,Weinmann Hanns-Joachim,Pietsch Hubertus

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-008-0977-y.pdf

Reference30 articles.

1. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188:586–592

2. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001

3. US FDA (2007) Information on gadolinium-containing contrast agents. http://www.fda.gov/cder/drug/infopage/gcca/ . Accessed 7 April 2008

4. Saab G, Abu-Alfa A, Sadowski EA, Djamali A (2007) Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis? Radiology 244:930–932

5. DeHoratius DM, Cowper SE (2006) Nephrogenic systemic fibrosis: an emerging threat among renal patients. Semin Dial 19:191–194

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient segmentation of active and inactive plaques in FLAIR-images using DeepLabV3Plus SE with efficientnetb0 backbone in multiple sclerosis;Scientific Reports;2024-07-15

2. The effect of delay time after injecting gadobutrol on the diagnosis of endolymphatic hydrops;Magnetic Resonance Imaging;2024-04

3. Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations;Investigative Radiology;2024-03-01

4. Efficient Segmentation of Active and Inactive Plaques in FLAIR-Images Using DeepLabV3Plus SE with EfficientNetB0 Backbone in Multiple Sclerosis;2023-12-04

5. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward;European Radiology;2023-10-07